Gurugram-based mental wellness startup Lissun is in talks to raise around ₹45 crore, or about $4.7 million, in a Series A round. Colossa Ventures is expected to lead the proposed deal, while some of Lissun’s current investors may also take part.
The talks were reported on July 7, 2026, and sources said the deal was at an advanced stage. If completed, the round could value Lissun at around ₹140 crore, or about $15 million. At the time of the report, neither Lissun nor Colossa Ventures had confirmed the deal.
The proposed fund raise shows the growing interest in mental healthcare startups in India. It also gives Lissun a chance to build a larger care network and reach more people who need help with mental health and child development.
What Lissun Does
Lissun was founded in 2021 by Krishna Veer Singh and Tarun Gupta. The company runs a tech-enabled mental and emotional health platform. Its service connects people with psychologists, psychiatrists, counsellors and other specialists.
The company uses both online and offline services. This gives users more than one way to access care. A person can seek support through digital services or visit a physical centre for care.
Lissun also has services beyond standard mental health support. Its platform offers self-help tools, child development services and enterprise mental wellness programmes. This gives the company a wider place in the health and wellness market.
A Wider Focus on Child Development
One important part of Lissun’s work is child development. The company has a network that includes speech therapists, occupational therapists, counsellors and special educators.
These professionals can help children and families deal with a range of mental health and developmental concerns. Early support can matter a lot for children because parents may need expert advice before a problem becomes harder to manage.
Lissun’s child development work therefore sits beside its wider mental health service. The company wants to make professional care easier to access and help people find support at an early stage.
This part of the business could also give Lissun a path to build more specialised centres across different cities.
Colossa Ventures May Lead the Round
Colossa Ventures, a Mumbai-based venture capital firm, is expected to lead the proposed Series A. Existing Lissun investors such as Rainmatter, IPV and RPSG are also expected to take part, according to the report.
The possible support from existing investors is important. It suggests that earlier backers may want to continue their relationship with the company as it enters its next stage.
However, the ₹45 crore deal was still under discussion when the report came out. Lissun and Colossa Ventures did not respond to questions from Inc42 before publication. Therefore, the amount should be treated as a proposed fund raise, not as money that Lissun had already received.
Lissun Has Raised Money Before
The proposed Series A comes almost two years after Lissun’s earlier major fund raise.
In 2024, the company raised $2.5 million in a pre-Series A round led by RPSG Capital Ventures. The deal also had participation from Multiply Ventures, Atrium Angels, IvyCap Ventures, Rainmatter and SucSEED Ventures, among others.
That earlier capital helped the company build its mental health platform and expand its services. The proposed new round would give Lissun another large pool of capital at a time when demand for mental healthcare services is receiving more attention.
The latest proposed deal would also be much larger than the previous $2.5 million round. A $4.7 million Series A could give the company more room to add centres, hire professionals and improve its technology.
A Growing Mental Health Market
Lissun operates at a time when mental health has become a larger part of India’s healthcare discussion.
People now have more access to online therapy, counselling and psychiatric care than they did in the past. At the same time, awareness about mental health has also grown.
For a company such as Lissun, this creates a large potential market. The startup can serve people who want online support as well as those who prefer a physical centre.
Its focus on several types of care may also help it serve different groups. Adults can seek mental health support, companies can use workplace wellness programmes, and parents can seek help through child development services.
Inc42 cited a projection that India’s healthtech market could reach $37 billion by 2030, with a 25% compound annual growth rate.
Competition Is Strong
Lissun is not alone in this market. It competes with mental health platforms such as Amaha, Sukoon, Trijog, YourDOST and Mitsu.
Each company has its own approach to mental healthcare. Some focus more on online therapy, while others use a wider mix of digital and offline services.
For Lissun, the challenge will be to build trust with users and make its care easy to access. Mental healthcare is different from many other online services because people often need a long-term relationship with a doctor, therapist or counsellor.
The quality of care can therefore matter as much as the technology behind the service.
Why the New Round Matters
If the proposed ₹45 crore deal closes, Lissun could use the money to increase its reach across India. A larger capital base can help the startup add more professionals and improve its centres.
It can also help the company build better digital tools. Technology can make it easier for users to find the right specialist, book a session and stay connected with their care team.
Child development could be another key area for expansion. Lissun already has professionals such as speech therapists, occupational therapists and special educators. More capital could help the company bring these services to more families.
The proposed funding may also help Lissun strengthen its business side. Enterprise mental wellness is another part of its platform, so the company can work with businesses as well as individual users.
A Higher Proposed Valuation
The proposed deal could value Lissun at around ₹140 crore, or roughly $15 million. This would mark a higher value for the company compared with its earlier stages.
Venture investors usually look for companies that can grow fast after a new round. For Lissun, that means the next phase will be important.
The company will need to show that it can use fresh capital well, grow its user base, build strong care services and create a business model that can support long-term growth.
A higher valuation also creates more pressure. Investors will expect clear progress after the fund raise.
The Road Ahead
Lissun has built a broad mental health platform since its start in 2021. Its work now covers mental and emotional health, child development, self-help tools and workplace wellness.
The proposed ₹45 crore Series A could give the company the funds it needs for its next stage. Colossa Ventures is expected to lead the round, while existing investors such as Rainmatter, IPV and RPSG may also take part.
But the key point is that the deal was still in talks when the news came out. It should not be described as a completed ₹45 crore fund raise.
For Lissun, the opportunity is clear. India has a large need for accessible mental healthcare, and digital tools can help more people find the right support. The company now has to prove that its mix of online services, offline centres and specialist care can grow in a strong and competitive market.
If the Series A closes as proposed, it could mark an important new chapter for Lissun. The next few years will show whether the company can turn investor support into wider access to mental healthcare and a stronger position in India’s growing healthtech sector.
Also Read – Visaible.ai Raises $1 Million to Help Hotels Win AI Search